Xcovery Raises $20M through Equity Investment from China’s Betta Pharmaceuticals for Development of ALK Inhibitor

Posted by on Oct 30, 2014 in Newsroom | 0 comments

WEST PALM BEACH, FL. – Xcovery, a developer of next-generation targeted therapeutics for cancer, today announced a commitment for a $20 million equity investment from Betta Pharmaceuticals Co., a leading Chinese pharmaceutical company focused on discovering, developing and delivering innovative medicines. In addition to the equity investment in Xcovery, Betta will gain Chinese rights to X-396, a potent small molecule anaplastic lymphoma kinase (ALK) inhibitor currently in a Phase 1/2 expansion cohort. “This significant investment from Betta Pharmaceuticals, a company that has...

Read More

Now Accepting Nominations until 10/31/14- Georgia Bio Awards Dinner

Posted by on Oct 29, 2014 in Newsroom | 0 comments

Each year Georgia Bio recognizes achievement and honors excellence in the list sciences industry in Georgia, as it brings together nearly 300 of the state’s life sciences industry leaders. The Awards Ceremony is a celebration of the contribution and achievements of Georgia, a moment to pause a reflect on the industry’s legacy.  Additionally the Awards Dinner serves as a fundraiser for the Georgia BioEd Institute; helping to raise funds for the bioscience workforce training and STEM programs the Institute offers throughout the state. The 2015 Awards Dinner will take place on...

Read More

Roskamp Institute Discovers New Target for Drugs to Treat Alzheimer’s Disease

Posted by on Oct 29, 2014 in Newsroom | 0 comments

SARASOTA, FL. –   Scientists at the Roskamp Institute (www.rfdn.org), a not-for-profit biomedical research facility specializing in Alzheimer’s disease research, have isolated a key molecule that gives researchers a new drug target for the treatment of the progressive, irreversible neurological disorder. This finding is the culmination of more than 10 years of work by more than a dozen scientists and clinicians in the research team in Sarasota. Alzheimer’s has been the subject of intensive research for more than 20 years. As yet, there is no approved treatment that...

Read More

Student Researchers Recognized at UA’s NanoBio Summit

Posted by on Oct 29, 2014 in Newsroom | 0 comments

TUSCALOOSA, AL. – Judges selected seven student presenters as winners for their research poster presentations given during a recent scientific forum on nanotechnology and biotechnology hosted by The University of Alabama. Four undergraduate and three graduate students, representing various universities, were recognized for their work during the NanoBio Summit 2014. “The summit brought 200 students, faculty, researchers and state and federal program officials to The University of Alabama campus,” said Dr. Carl A. Pinkert, vice president for research and economic development at UA....

Read More

iDTx Systems, Inc. Receives 2nd US Patent in October

Posted by on Oct 29, 2014 in Newsroom | 0 comments

CHARLESTON, S.C. – iDTx Systems Inc. announced today the issue of US Patent #8,869,793 titled Compact self-contained automated MDI adapters or units for ventilators.  US Patent #8,857,429 titled Drug delivery and monitoring system for a ventilator issued on October 14, 2014. “With this second US patent issued to iDTx Systems within a month, we are staking out a strong proprietary position around the automation of aerosol drug delivery to ventilator-dependent patients.  Other patent applications are pending both in the US and internationally.”  said Pearce Gilbert, Chief Executive...

Read More

SCRA Technology Ventures Presents Investment

Posted by on Oct 29, 2014 in Newsroom | 0 comments

GREENVILLE, S.C. – SCRA Technology Ventures presented a “big check” to International BioMedical Devices (IBMD) during the Charleston Chamber of Commerce’s Launchpad event. The big check ceremony formally honors and congratulates companies on their investment closings. IBMD received investment approval in August. “It is with pleasure that we recognize this promising company that is working to reduce surgical time and improve patient outcomes with their technology” IBMD is a Charleston-based medical device company focused in the field of ophthalmic surgery. The...

Read More